DEBASISH TRIPATHY to Immunohistochemistry
This is a "connection" page, showing publications DEBASISH TRIPATHY has written about Immunohistochemistry.
Connection Strength
0.050
-
Effect of cardiac dysfunction on treatment outcomes in women receiving trastuzumab for HER2-overexpressing metastatic breast cancer. Clin Breast Cancer. 2004 Oct; 5(4):293-8.
Score: 0.027
-
Evaluation of cMET aberration by immunohistochemistry and fluorescence in situ hybridization (FISH) in triple negative breast cancers. Ann Diagn Pathol. 2018 Aug; 35:69-76.
Score: 0.018
-
Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer. J Clin Oncol. 2002 Feb 01; 20(3):719-26.
Score: 0.006